Old Web
English
Sign In
Acemap
>
Paper
>
P1.01-84 High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC
P1.01-84 High Basal Serum EGF Levels Predicts Response to CIMAvax-EGF, a Therapeutic Vaccine for Advanced NSCLC
2018
O. Santos Morales
Patricia Lorenzo Luaces
Tania Crombet
Camilo Rodríguez
Elia Neninger
Keywords:
Basal (phylogenetics)
Therapeutic vaccine
Pathology
Oncology
CimaVax-EGF
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]